Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

Basel

SGPP Annual Congress/PSY Congress 2025

"Psyche, Human, Brain – Psychiatry at the Center" forms the central theme of the 2025 edition. The program promises insightful keynote speeches and state-of-the-art presentations [...]

Go to Top